Systemic lupus erythematosus and COVID-19
M Pappa, A Panagiotopoulos, K Thomas… - Current Rheumatology …, 2023 - Springer
Abstract Purpose of Review To describe the current state of knowledge regarding COVID-19
in patients with systemic lupus erythematosus (SLE). We focus on (i) SARS-CoV-2 …
in patients with systemic lupus erythematosus (SLE). We focus on (i) SARS-CoV-2 …
A Comprehensive Assessment of Environmental Implications, Ecotoxicity and Bioaccumulation Potential of Repurposed Drug Hydroxychloroquine: From Challenges …
P Gupta, V Rani - Reviews of Environmental Contamination and …, 2024 - Springer
An unprecedented rise in the demand for the drug hydroxychloroquine (HCQ) worldwide
and its utilisation has resulted in its upscale manufacturing. Being ecologically persistent …
and its utilisation has resulted in its upscale manufacturing. Being ecologically persistent …
Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023
C Abud-Mendoza, FJ Aceves-Ávila… - … Clínica (English Edition), 2024 - Elsevier
Objective To develop updated guidelines for the pharmacological management of
rheumatoid arthritis (RA). Methods A group of experts representative of different …
rheumatoid arthritis (RA). Methods A group of experts representative of different …
Cardiovascular profile of systemic lupus erythematosus patients hospitalized for COVID-19 in Spain: Analysis of the SEMI-COVID-19 Registry
H Hernández-Negrín, MR Bernal-López… - Medicina Clínica, 2025 - Elsevier
Background Despite advancements in understanding the interplay between systemic lupus
erythematosus (SLE), cardiovascular disease and COVID-19, challenges and knowledge …
erythematosus (SLE), cardiovascular disease and COVID-19, challenges and knowledge …
Characteristics of SLE patients with symptomatic COVID-19: Single centre experience at Sultan Qaboos University Hospital over a 30-month period
KS Hassan, B Al Lawati, GA Rizvi - Lupus, 2023 - journals.sagepub.com
Background COVID-19 pandemic was declared by WHO in March 2020. Severity of disease
varied from asymptomatic to fatal infection. Severe disease was found to be associated with …
varied from asymptomatic to fatal infection. Severe disease was found to be associated with …
Saudi National Clinical Practice Guidelines for Management of Adult Systemic Lupus Erythematosus
AH Al-Jedai, HY Almudaiheem… - Current …, 2025 - benthamdirect.com
Objective To provide evidence-based clinical practice recommendations for managing
Systemic Lupus Erythematosus (SLE) in Saudi Arabia. Methods This EULAR-adapted …
Systemic Lupus Erythematosus (SLE) in Saudi Arabia. Methods This EULAR-adapted …
COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis
I Landsteiner de Sampaio Amêndola… - Journal of Clinical …, 2022 - mdpi.com
The ongoing chronic use of hydroxychloroquine or chloroquine (HCQ/CQ) in rheumatic
patients might impact their outcomes after a SARS-CoV-2 infection. Therefore, we sought to …
patients might impact their outcomes after a SARS-CoV-2 infection. Therefore, we sought to …
Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023
C Abud-Mendoza, FJ Aceves-Ávila… - Reumatología …, 2024 - Elsevier
Objetivo Desarrollar guías actualizadas para el manejo farmacológico de la artritis
reumatoide (AR). Métodos Se conformó un grupo de expertos que fueran representativos de …
reumatoide (AR). Métodos Se conformó un grupo de expertos que fueran representativos de …
Does the use of corticosteroids and immunosuppressants increase the risk of COVID-19 infection among people with systemic lupus erythematosus?
Objective An important clinical question is whether the use of immunosuppressants or
corticosteroids increases the risk of incident COVID-19 disease among patients with SLE. To …
corticosteroids increases the risk of incident COVID-19 disease among patients with SLE. To …